Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 714

1.

Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis.

Oyama M, Okada K, Masuda M, Shimizu Y, Yokoyama K, Uzawa A, Kawaguchi N, Ikeguchi R, Hoshino Y, Hatano T, Ozawa Y, Nakahara J, Aizawa H, Kitagawa K, Hattori N, Kuwabara S, Murai H, Suzuki S.

Ther Adv Neurol Disord. 2020 Mar 18;13:1756286420904207. doi: 10.1177/1756286420904207. eCollection 2020.

2.

Advanced diffusion magnetic resonance imaging in patients with Alzheimer's and Parkinson's diseases.

Kamagata K, Andica C, Hatano T, Ogawa T, Takeshige-Amano H, Ogaki K, Akashi T, Hagiwara A, Fujita S, Aoki S.

Neural Regen Res. 2020 Sep;15(9):1590-1600. doi: 10.4103/1673-5374.276326. Review.

PMID:
32209758
3.

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease.

Oji Y, Hatano T, Ueno SI, Funayama M, Ishikawa KI, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N.

Brain. 2020 Mar 23. pii: awaa064. doi: 10.1093/brain/awaa064. [Epub ahead of print]

PMID:
32201884
4.

A Case of Ischemic Stroke With Congenital Protein C Deficiency and Carotid Web Successfully Treated by Anticoagulant and Carotid Stenting.

Watanabe S, Matsumoto S, Nakahara I, Ishii A, Hatano T, Mori M, Morishita E, Nagata I.

Front Neurol. 2020 Feb 18;11:99. doi: 10.3389/fneur.2020.00099. eCollection 2020.

5.

Impact of thrombus migration on clinical outcomes in patients with internal carotid artery occlusions and patent middle cerebral artery.

Koge J, Matsumoto S, Nakahara I, Ishii A, Hatano T, Tanaka Y, Kondo D, Kira JI, Nagata I.

J Neurol Sci. 2020 Feb 15;412:116737. doi: 10.1016/j.jns.2020.116737. [Epub ahead of print]

PMID:
32087429
6.

Universal Relaxation Dynamics of Sphere Packings below Jamming.

Ikeda A, Kawasaki T, Berthier L, Saitoh K, Hatano T.

Phys Rev Lett. 2020 Feb 7;124(5):058001. doi: 10.1103/PhysRevLett.124.058001.

PMID:
32083930
7.

Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules.

Ogawa T, Hatano T, Oyama G, Takanashi M, Taniguchi D, Hattori N.

Mov Disord Clin Pract. 2020 Jan 20;7(2):240-242. doi: 10.1002/mdc3.12894. eCollection 2020 Feb. No abstract available.

PMID:
32071951
8.

Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.

Ueno SI, Hatano T, Okuzumi A, Saiki S, Oji Y, Mori A, Koinuma T, Fujimaki M, Takeshige-Amano H, Kondo A, Yoshikawa N, Nojiri T, Kurano M, Yasukawa K, Yatomi Y, Ikeda H, Hattori N.

Ann Clin Transl Neurol. 2020 Mar;7(3):307-317. doi: 10.1002/acn3.50990. Epub 2020 Feb 14.

9.

Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report.

Yamashita Y, Ogawa T, Ogaki K, Kamo H, Sukigara T, Kitahara E, Izawa N, Iwamuro H, Oyama G, Kamagata K, Hatano T, Umemura A, Kosaki R, Kubota M, Shimo Y, Hattori N.

J Neurol Sci. 2020 Apr 15;411:116710. doi: 10.1016/j.jns.2020.116710. Epub 2020 Jan 31. No abstract available.

PMID:
32044685
10.

Neurocognitive and psychiatric disorders-related axonal degeneration in Parkinson's disease.

Andica C, Kamagata K, Hatano T, Saito Y, Uchida W, Ogawa T, Takeshige-Amano H, Hagiwara A, Murata S, Oyama G, Shimo Y, Umemura A, Akashi T, Wada A, Kumamaru KK, Hori M, Hattori N, Aoki S.

J Neurosci Res. 2020 May;98(5):936-949. doi: 10.1002/jnr.24584. Epub 2020 Feb 5.

PMID:
32026517
11.

Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure.

Bautista JMP, Oyama G, Nuermaimaiti M, Sekimoto S, Sasaki F, Hatano T, Nishioka K, Ito M, Umemura A, Ishibashi Y, Shimo Y, Hattori N.

J Mov Disord. 2020 Jan;13(1):57-61. doi: 10.14802/jmd.19051. Epub 2020 Jan 31.

12.

Pick-ya actin - a method to purify actin isoforms with bespoke key post-translational modifications.

Hatano T, Sivashanmugam L, Suchenko A, Hussain H, Balasubramanian MK.

J Cell Sci. 2020 Jan 30;133(2). pii: jcs241406. doi: 10.1242/jcs.241406.

13.

Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.

Hatano T, Egawa S.

Asian J Surg. 2020 Jan 17. pii: S1015-9584(20)30003-8. doi: 10.1016/j.asjsur.2019.12.008. [Epub ahead of print] Review.

14.

Soft X-ray spectral analysis of laser produced molybdenum plasmas using the fundamental and second harmonics of a Nd:YAG laser.

Lokasani R, Kawasaki H, Shimada Y, Shoji M, Anraku K, Ejima T, Hatano T, Jiang W, Namba S, Nikl J, Zeman M, O'Sullivan G, Higashiguchi T, Limpouch J.

Opt Express. 2019 Nov 11;27(23):33351-33358. doi: 10.1364/OE.27.033351.

PMID:
31878405
15.

Determinants of Low Body Mass Index in Patients with Parkinson's Disease: A Multicenter Case-Control Study.

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Haruyama Y, Kobashi G, Sakakibara R, Shimo Y, Hatano T, Hattori N, Yamamoto T, Hirano S, Yamamoto T, Kuwabara S, Kaji Y, Fujita H, Kadowaki T, Hirata K.

J Parkinsons Dis. 2020;10(1):213-221. doi: 10.3233/JPD-191741.

PMID:
31868678
16.

Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator.

Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Thromb Thrombolysis. 2019 Dec 17. doi: 10.1007/s11239-019-02015-4. [Epub ahead of print]

PMID:
31848874
17.

MR biomarkers of degenerative brain disorders derived from diffusion imaging.

Andica C, Kamagata K, Hatano T, Saito Y, Ogaki K, Hattori N, Aoki S.

J Magn Reson Imaging. 2019 Dec 13. doi: 10.1002/jmri.27019. [Epub ahead of print] Review.

PMID:
31837086
18.

Real-world Treatment Outcomes of the EXTREME Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multi-center Retrospective Cohort Study in Japan.

Sano D, Fujisawa T, Tokuhisa M, Shimizu M, Sakagami T, Hatano T, Nishimura G, Ichikawa Y, Iwai H, Oridate N.

Anticancer Res. 2019 Dec;39(12):6819-6827. doi: 10.21873/anticanres.13898.

PMID:
31810948
19.

Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.

Toyoda K, Koga M, Iguchi Y, Itabashi R, Inoue M, Okada Y, Ogasawara K, Tsujino A, Hasegawa Y, Hatano T, Yamagami H, Iwama T, Shiokawa Y, Terayama Y, Minematsu K.

Neurol Med Chir (Tokyo). 2019 Dec 15;59(12):449-491. doi: 10.2176/nmc.st.2019-0177. Epub 2019 Dec 5. No abstract available.

20.

Freezing of gait in Parkinson's disease may share the mechanisms of dystonia.

Shimo Y, Hatano T, Sakurai M, Sekimoto S, Marisdina S, Hattori N.

Neurol Sci. 2019 Nov 27. doi: 10.1007/s10072-019-04155-0. [Epub ahead of print] No abstract available.

PMID:
31776866
21.

Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.

Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Thromb Thrombolysis. 2019 Nov 19. doi: 10.1007/s11239-019-01979-7. [Epub ahead of print]

PMID:
31745858
22.

A Visual Task Management Application for Acute Ischemic Stroke Care.

Matsumoto S, Koyama H, Nakahara I, Ishii A, Hatano T, Ohta T, Tanaka K, Ando M, Chihara H, Takita W, Tokunaga K, Hashikawa T, Funakoshi Y, Kamata T, Higashi E, Watanabe S, Kondo D, Tsujimoto A, Furuta K, Ishihara T, Hashimoto T, Koge J, Sonoda K, Torii T, Nakagaki H, Yamasaki R, Nagata I, Kira JI.

Front Neurol. 2019 Oct 30;10:1118. doi: 10.3389/fneur.2019.01118. eCollection 2019.

23.

Evaluation of white matter microstructure in patients with Parkinson's disease using microscopic fractional anisotropy.

Ikenouchi Y, Kamagata K, Andica C, Hatano T, Ogawa T, Takeshige-Amano H, Kamiya K, Wada A, Suzuki M, Fujita S, Hagiwara A, Irie R, Hori M, Oyama G, Shimo Y, Umemura A, Hattori N, Aoki S.

Neuroradiology. 2020 Feb;62(2):197-203. doi: 10.1007/s00234-019-02301-1. Epub 2019 Nov 4.

PMID:
31680195
24.

Long-term Outcomes After Intraprocedural Aneurysm Rupture During Coil Embolization of Unruptured Intracranial Aneurysms.

Yamagami K, Hatano T, Nakahara I, Ishii A, Ando M, Chihara H, Ogura T, Suzuki K, Kondo D, Kamata T, Higashi E, Sakai S, Sakamoto H, Iihara K, Nagata I.

World Neurosurg. 2020 Feb;134:e289-e297. doi: 10.1016/j.wneu.2019.10.038. Epub 2019 Oct 16.

PMID:
31629140
25.

Phosphoregulation of tropomyosin is crucial for actin cable turnover and division site placement.

Palani S, Köster DV, Hatano T, Kamnev A, Kanamaru T, Brooker HR, Hernandez-Fernaud JR, Jones AME, Millar JBA, Mulvihill DP, Balasubramanian MK.

J Cell Biol. 2019 Nov 4;218(11):3548-3559. doi: 10.1083/jcb.201809089. Epub 2019 Oct 9.

26.

A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer.

Nishimura G, Sano D, Arai Y, Hatano T, Takahashi H, Tanabe T, Wada T, Morishita D, Oridate N.

Cancer Med. 2019 Dec;8(17):7197-7206. doi: 10.1002/cam4.2588. Epub 2019 Oct 8.

27.

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.

Mori A, Ishikawa KI, Saiki S, Hatano T, Oji Y, Okuzumi A, Fujimaki M, Koinuma T, Ueno SI, Imamichi Y, Hattori N.

PLoS One. 2019 Sep 27;14(9):e0223113. doi: 10.1371/journal.pone.0223113. eCollection 2019.

28.

Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.

Mori A, Hatano T, Inoshita T, Shiba-Fukushima K, Koinuma T, Meng H, Kubo SI, Spratt S, Cui C, Yamashita C, Miki Y, Yamamoto K, Hirabayashi T, Murakami M, Takahashi Y, Shindou H, Nonaka T, Hasegawa M, Okuzumi A, Imai Y, Hattori N.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20689-20699. doi: 10.1073/pnas.1902958116. Epub 2019 Sep 23.

29.

Structures, NMR Spectroscopic Features, and Cytotoxic Properties of Oligomeric Hellinoyl (m-GO-m-GOG)-Type Ellagitannins from the Galls of Tamarix aphylla.

Orabi MAA, Orabi EA, Taniguchi S, Sakagami H, Yoshimura M, Amakura Y, Hatano T.

J Nat Prod. 2019 Oct 25;82(10):2682-2695. doi: 10.1021/acs.jnatprod.9b00073. Epub 2019 Sep 18.

PMID:
31532650
30.

Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer.

Mori K, Kimura T, Fukuokaya W, Iwatani K, Sakanaka K, Kurokawa G, Yanagisawa T, Sasaki H, Miki J, Shimomura T, Miki K, Hatano T, Endo K, Egawa S.

Int J Clin Oncol. 2020 Mar;25(3):479-485. doi: 10.1007/s10147-019-01541-8. Epub 2019 Sep 11.

PMID:
31512007
31.

Modulation of TOR complex 2 signaling by the stress-activated MAPK pathway in fission yeast.

Morigasaki S, Chin LC, Hatano T, Emori M, Iwamoto M, Tatebe H, Shiozaki K.

J Cell Sci. 2019 Oct 10;132(19). pii: jcs236133. doi: 10.1242/jcs.236133.

PMID:
31477575
32.

Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson's Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).

Sato K, Aita N, Hokari Y, Kitahara E, Tani M, Izawa N, Hatori K, Nakamura R, Sasaki F, Sekimoto S, Jo T, Oyama G, Hatano T, Shimo Y, Iwamuro H, Umemura A, Hattori N, Fujiwara T.

Parkinsons Dis. 2019 Aug 4;2019:7104071. doi: 10.1155/2019/7104071. eCollection 2019.

33.

Thrombosis of Large Aneurysm Induced by Flow-Diverter Stent and Dissolved by Direct Factor Xa Inhibitor.

Higashi E, Hatano T, Ando M, Chihara H, Ogura T, Suzuki K, Yamagami K, Kondo D, Kamata T, Sakai S, Sakamoto H, Nagata I.

World Neurosurg. 2019 Nov;131:209-212. doi: 10.1016/j.wneu.2019.08.053. Epub 2019 Aug 20.

PMID:
31442658
34.

Predicting Clinical Outcomes of Large Vessel Occlusion Before Mechanical Thrombectomy Using Machine Learning.

Nishi H, Oishi N, Ishii A, Ono I, Ogura T, Sunohara T, Chihara H, Fukumitsu R, Okawa M, Yamana N, Imamura H, Sadamasa N, Hatano T, Nakahara I, Sakai N, Miyamoto S.

Stroke. 2019 Sep;50(9):2379-2388. doi: 10.1161/STROKEAHA.119.025411. Epub 2019 Aug 14.

PMID:
31409267
35.

Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.

Tanaka K, Matsumoto S, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104305. doi: 10.1016/j.jstrokecerebrovasdis.2019.104305. Epub 2019 Aug 10.

PMID:
31405791
36.

Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI.

Le Berre A, Kamagata K, Otsuka Y, Andica C, Hatano T, Saccenti L, Ogawa T, Takeshige-Amano H, Wada A, Suzuki M, Hagiwara A, Irie R, Hori M, Oyama G, Shimo Y, Umemura A, Hattori N, Aoki S.

Neuroradiology. 2019 Dec;61(12):1387-1395. doi: 10.1007/s00234-019-02279-w. Epub 2019 Aug 10.

37.

Free-Water Imaging in White and Gray Matter in Parkinson's Disease.

Andica C, Kamagata K, Hatano T, Saito A, Uchida W, Ogawa T, Takeshige-Amano H, Zalesky A, Wada A, Suzuki M, Hagiwara A, Irie R, Hori M, Kumamaru KK, Oyama G, Shimo Y, Umemura A, Pantelis C, Hattori N, Aoki S.

Cells. 2019 Aug 5;8(8). pii: E839. doi: 10.3390/cells8080839.

38.

Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.

Kamo H, Hatano T, Kanai K, Aoki N, Kamiyama D, Yokoyama K, Takanashi M, Yamashita Y, Shimo Y, Hattori N.

BMC Neurol. 2019 Aug 5;19(1):184. doi: 10.1186/s12883-019-1416-1.

39.

Combined Method with Free Omentum Flap and Split-thickness Skin Flap for Hand Reconstruction Following Radical Excision of an Arteriovenous Malformation.

Hatano T, Motomura H, Deguchi A, Fujikawa H, Maeda S.

Plast Reconstr Surg Glob Open. 2019 May 3;7(5):e2186. doi: 10.1097/GOX.0000000000002186. eCollection 2019 May.

40.

[Ⅲ.The Advances in Research of Human Papillomavirus-Induced Carcinogenesis in Oropharyngeal Cancers].

Hatano T, Sano D, Oridate N.

Gan To Kagaku Ryoho. 2019 Jul;46(7):1128-1130. Japanese. No abstract available.

PMID:
31296817
41.

Factors Associated with Postprocedural Diffusion-Weighted Imaging-Positive Lesions in Endovascular Treatment for Unruptured Cerebral Aneurysms.

Tokunaga K, Hatano T, Nakahara I, Ishii A, Higashi E, Kamata T, Funakoshi Y, Hashikawa T, Takita W, Chihara H, Ando M, Sadamasa N, Kitazono T, Nagata I.

World Neurosurg. 2019 Oct;130:e457-e462. doi: 10.1016/j.wneu.2019.06.114. Epub 2019 Jun 24.

PMID:
31247348
42.

A metabolic profile of polyamines in parkinson disease: A promising biomarker.

Saiki S, Sasazawa Y, Fujimaki M, Kamagata K, Kaga N, Taka H, Li Y, Souma S, Hatano T, Imamichi Y, Furuya N, Mori A, Oji Y, Ueno SI, Nojiri S, Miura Y, Ueno T, Funayama M, Aoki S, Hattori N.

Ann Neurol. 2019 Aug;86(2):251-263. doi: 10.1002/ana.25516. Epub 2019 Jul 1.

43.

Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease?

Okuzumi A, Hatano T, Kamagata K, Hori M, Mori A, Oji Y, Taniguchi D, Daida K, Shimo Y, Yanagisawa N, Nojiri S, Aoki S, Hattori N.

Eur J Neurol. 2019 Nov;26(11):1408-1416. doi: 10.1111/ene.14009. Epub 2019 Jun 24.

44.

Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson's disease.

Ishibashi Y, Shimo Y, Yube Y, Oka S, Egawa H, Kohira Y, Kaji S, Kanda S, Oyama G, Hatano T, Hattori N, Fukunaga T.

Scand J Gastroenterol. 2019 Jun;54(6):787-792. doi: 10.1080/00365521.2019.1619830. Epub 2019 May 24.

PMID:
31125265
45.

Tau aggregation and seeding analyses of two novel MAPT variants found in patients with motor neuron disease and progressive parkinsonism.

Nakayama S, Shimonaka S, Elahi M, Nishioka K, Oji Y, Matsumoto SE, Li Y, Yoshino H, Mogushi K, Hatano T, Sato T, Ikura T, Ito N, Motoi Y, Hattori N.

Neurobiol Aging. 2019 Dec;84:240.e13-240.e22. doi: 10.1016/j.neurobiolaging.2019.02.016. Epub 2019 Mar 1.

PMID:
31027853
46.

Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma.

Hatano T, Matsu-Ura T, Mori KI, Inaba H, Endo K, Tamari M, Egawa S.

Jpn J Clin Oncol. 2019 May 1;49(5):473-476. doi: 10.1093/jjco/hyz038.

PMID:
30920617
47.

Metabolomics-based identification of metabolic alterations in PARK2.

Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N.

Ann Clin Transl Neurol. 2019 Feb 21;6(3):525-536. doi: 10.1002/acn3.724. eCollection 2019 Mar.

48.

Generation of hydrogen sulfide from sulfur assimilation in Escherichia coli.

Tanaka N, Hatano T, Saito S, Wakabayashi Y, Abe T, Kawano Y, Ohtsu I.

J Gen Appl Microbiol. 2019 Dec 19;65(5):234-239. doi: 10.2323/jgam.2018.11.001. Epub 2019 Mar 15.

49.

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.

Ikeda A, Shimada H, Nishioka K, Takanashi M, Hayashida A, Li Y, Yoshino H, Funayama M, Ueno Y, Hatano T, Sahara N, Suhara T, Higuchi M, Hattori N.

Mov Disord. 2019 Apr;34(4):568-574. doi: 10.1002/mds.27623. Epub 2019 Feb 17.

50.

A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson's Disease.

Sekimoto S, Oyama G, Hatano T, Sasaki F, Nakamura R, Jo T, Shimo Y, Hattori N.

Parkinsons Dis. 2019 Jan 6;2019:9403295. doi: 10.1155/2019/9403295. eCollection 2019.

Supplemental Content

Loading ...
Support Center